These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34768707)

  • 1. Epstein-Barr Virus Prevalence at Diagnosis and Seroconversion during Follow-Up in Pediatric Inflammatory Bowel Disease.
    Bachmann J; Le Thi G; Brückner A; Kalteis AL; Schwerd T; Koletzko S; Lurz E
    J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
    Zhang H; Zhao S; Cao Z
    Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
    de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
    Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Infection and Thiopurine Therapy in a Pediatric Population with Inflammatory Bowel Disease.
    Espinheira MDC; Pais IP; Afonso I; Ferreira J; Trindade E; Amil-Dias J
    GE Port J Gastroenterol; 2020 Aug; 27(5):318-323. PubMed ID: 32999904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus seroprevalence and viral load at disease onset in children with inflammatory bowel disease.
    Kornitzer G; Rosenstein M; Turcotte MC; Godin D; Groleau V; Renaud C; Touzot F; Jantchou P; Ovetchkine P; Deslandres C
    JGH Open; 2022 Sep; 6(9):625-629. PubMed ID: 36091316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus seroprevalence among inflammatory bowel disease patients in Saudi Arabia.
    Al-Bawardy B; Alfadley AF; Almousallam M; AlShathri S; Aboueissa M; Alsulaiman A; Attamimi M; AlMutairdi A
    Saudi J Gastroenterol; 2024 May; 30(3):168-172. PubMed ID: 38358251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis caused by primary Epstein-Barr virus in patient with Crohn's disease.
    Virdis F; Tacci S; Messina F; Varcada M
    World J Gastrointest Surg; 2013 Nov; 5(11):306-8. PubMed ID: 24520429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and endoscopic complications of Epstein-Barr virus in inflammatory bowel disease: an illustrative case series.
    Goetgebuer RL; van der Woude CJ; de Ridder L; Doukas M; de Vries AC
    Int J Colorectal Dis; 2019 May; 34(5):923-926. PubMed ID: 30739187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study.
    Linton MS; Kroeker K; Fedorak D; Dieleman L; Fedorak RN
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1248-54. PubMed ID: 24053733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
    Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV Status and Thiopurine Use in Pediatric IBD.
    Gordon J; Ramaswami A; Beuttler M; Jossen J; Pittman N; Lai J; Dunkin D; Benkov K; Dubinsky M
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):711-4. PubMed ID: 26655944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
    Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
    Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis.
    Biank VF; Sheth MK; Talano J; Margolis D; Simpson P; Kugathasan S; Stephens M
    J Pediatr; 2011 Nov; 159(5):808-12. PubMed ID: 21722918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung injury associated with severe Epstein-Barr virus (EBV) infection].
    Cui Y; Zhang Y; Wang F; Zhu Y; Chen R; Xu L
    Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):586-91. PubMed ID: 26717656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.
    Ellis D; Jaffe R; Green M; Janosky JJ; Lombardozzi-Lane S; Shapiro R; Scantlebury V; Vivas C; Jordan ML
    Transplantation; 1999 Oct; 68(7):997-1003. PubMed ID: 10532541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
    Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
    Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients.
    Wei HT; Xue XW; Ling Q; Wang PY; Zhou WX
    World J Gastrointest Surg; 2023 Mar; 15(3):420-429. PubMed ID: 37032795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
    Magro F; Santos-Antunes J; Albuquerque A; Vilas-Boas F; Macedo GN; Nazareth N; Lopes S; Sobrinho-Simões J; Teixeira S; Dias CC; Cabral J; Sarmento A; Macedo G
    Inflamm Bowel Dis; 2013 Jul; 19(8):1710-6. PubMed ID: 23574759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.
    Wu S; He C; Tang TY; Li YQ
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1085-1091. PubMed ID: 31205127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.